Twitter Beğeni Hilesi

Two signs that #TCT2022 is ending Luggage at the convention center and long lines for checking out at the Westin .

⭐️🇮🇹COPS multicenter randomized trial just out as LBCT #TCT2022 Cutting 🔪 vs. non-compliant (NC) 🎈 in Ca++ lesions At Ca++ site: 🔑 MSA: 8.1 vs. 7.3 mm2 (p =0.035) 🔑 Eccentricity index: 0.84 vs. 0.80 (p =0.013) antonio mangieri Antonio Colombo Damiano Regazzoli Gabriele Gasparini

See you all next year in San Francisco #TCT2023 😊 Thanks Boston!!#TCT2022

84y♀️ sever AS, perim 62,area 300, SOV 26.6, LM 6.8. #lifetime_management #TAVR Medtronic #evolute 23mm #cusp_overlap #commisural_alignment MPG 4, No AI, no ECG change Abdullah Alsaiedi I عبدالله السعيدي Mognee Alameer Rasha Al-Bawardy Dɾ Sααԃ Aʅ Bυɠαɱι. FSCAI د. سعد البقمي Dr. Jamilah AlRahimi TAVR Bot MIЯVΛƬ #IC Dr. Gilbert Tang Colum Owens

Dr. Gilbert Tang TCT Conference NEJM Dr Roxana Mehran George Dangas, MD, MACC, MSCAI David J. Cohen, MD, MSc MIЯVΛƬ #IC Sachin Goel Philippe Pibarot Pablo Lamelas 🇦🇷🇨🇦 TCTMD Kendra J. Grubb M.D. @PK_parasu Sahil Khera Rodrigo Bagur 🇦🇷🇨🇦 Jason Foerst NEGATIVE trial. Therefore subgroups are hypothesis generating at best. Second, no correction made for statistical chance so only point estimates for the many subgroups given in NEJM. Presentations and ads don’t undergo the same rigour, unfortunately, so a p value has snuck in.

Honored to present at #HongKongValves2022 alongside a great lineup of speakers. Hope to go back to my birthplace next year in person! #TAVR #FixTR #TMVR vinayak bapat Tsuyoshi Kaneko Univ.-Prof. Dr. Ralph Stephan von Bardeleben Jaffar Khan Maurizio taramasso RTHahnMD MIЯVΛƬ #IC Azeem Latib

80y♂️ severe AS heavily ca EF35%, RBBB, LAD prox-mid 90% calcified lesion. PCI to LAD then #TAVR with #evolute_29. Pre&post🎈. #commisural_alignment #cusp_overlap. shallow implant. No ECG↔️,PG3, NO AI. Easy coronary re-access. MIЯVΛƬ #IC ZeroTLR Rasha Al-Bawardy Abdullah Alsaiedi I عبدالله السعيدي

In this multicentre, propensity-matched comparison of the self-expanding ACURATE neo2 and the balloon-expandable SAPIEN 3 Ultra prostheses, the authors found comparably good short-term outcomes but some differences in device success and paravalvular leak. ow.ly/wsyG50LunWt

Don’t miss New York Transcatheter Valves today #NewYork Transcatheter Valve. World class speakers, 6 live #TAVR #TEER #TMVR cases! Mount Sinai Fuster Heart Hospital Mount Sinai Health System Icahn School of Medicine at Mount Sinai @DrSaminSharma DoctorKini Dr Roxana Mehran George Dangas, MD, MACC, MSCAI Sahil Khera Parasuram Krishnamoorthy MD @StamLerakis David L. Reich, MD Beth Oliver

1/Excited to share our recent CCIjournal publication on the incidence & distribution of missed paravalvular regurgitation (PVR) led by Dr. Syed Zaid Ahmad Abu-Haniyeh & Aaqib Malik MD MPH & huge thanks to @hasan_ahmadMD Joshua Goldberg Dr. Gilbert Tang 🔗onlinelibrary.wiley.com/doi/abs/10.100… A 🧵...

Amazing #ValvePPM app by vinayak bapat RTHahnMD Philippe Pibarot on avoiding PPM and check valve function with ref EOA in AVR MVR #TAVR. Must download now to benefit your pts! João Cavalcante MIЯVΛƬ #IC PCRonline 🫀 Cardiovascular Research Foundation Isaac George MD AATS The Society of Thoracic Surgeons EACTS European Society of Cardiology

First-in-human TELLTALE-BASILICA St. Francis Hospital & Heart Center! TELLTALE is the first and only dedicated system for transcatheter electrosurgical leaflet modification. Life is so much easier with dedicated devices - BASILICA took only a few minutes and the patient did great! Details at #crt2023

João Cavalcante #CRT23 Bicuspid Anatomy for TAVR The more calcification raphe leaflet LVOT worse mortality Shorter membranous septal length in BAV High LV-Ao angle >60 deg Concomitant coronary anomalies & coronary heights #Imaging 🔑 to BAV pt selection for TAVR

#CRT2023 Jaffar Khan on multivariate prediction model for coronary obstruction in native & ViV #TAVR — ✅ measure cusp ht:coronary ht/sinus ht ✅ measure VTC / VTSTJ (<4mm = ⬆️risk) ✅ measure leaflet calcium volume (>600mm3 = ⬆️risk) ➡️ sig improved sens/spec CRT Meeting

Current hs-cTn assays are highly valuable for rule-out of AMI. This comes at the price of specificity, unless serial assessments are made. However, serial testing does not differentiate Type 1 from Type 2 AMI and, therefore, robust clinical assessment remains crucial. #CRT2023

✨Glad to share at #CRT2023 our Montefiore Heart experience on Prophylactic IABP in TF-TAVI 🌐Out now EuroIntervention: eurointervention.pcronline.com/article/prophy… Azeem Latib Juan F. Granada Manaf Assafin Pier Pasquale Leone @MatteoMSturla Jonathan Curio Sebastian Ludwig Alexander M. Spring, MD Montefiore Health System Albert Einstein College of Medicine - Official Cardiovascular Research Foundation

Hypoattenuated Leaflet Thickening (HALT) Operative view of Sapien 3 implanted 6 months prior with #HALT of right and noncoronary leaflet. #TAVR

#CRT2023 PCI vs CABG for LM dz w & w/out DM 25% DM DM pts more likely to have higher Syntax & co-morbidities PEP: all cause ☠️ SEP: CVS & non-CVS ☠️,stroke, peri-procedural & spontaneous MI No difference in PEP btwn revasc strategy ⬆️ spontaneous MI & repeat revasc w PCI

85y♂️ NSTEMI, 5y ago had TAVI in embolized TAVI during same procedure. Today, PCI to RCA & angiogram to LM done (LAD non-viable). 5Fr RJC advanced over wire between the valves and aortic wall. Spacious STJ was helpful.

#TRILUMINATE #TEER #TriClip RCT American College of Cardiology #ACC2023 late breaker by Paul No diff vs GDMT in ☠️🏩but ⬆️KCCQ ⬇️TR at 1y. Pts DO feel better! Honored to be in this trial and my 1st paper NEJM! RTHahnMD Carlos E. Sanchez MD Sachin Goel MIЯVΛƬ #IC Sahil Khera Parasuram Krishnamoorthy MD